2022

1. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol

   Gates Open Research, Vol. 6

2. Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control

   The Lancet Infectious Diseases, Vol. 22, Núm. 11, pp. e341-e347